Intelligent OMICS Ltd

Did you catch our exciting announcement on Friday?! We are thrilled to welcome Jue Wang (Google DeepMind) and Robert Grundy MBE (Intelligent OMICS Ltd) as our keynote speakers for Research & Innovation 2025, taking place 10–11 March at The Royal Society of Medicine, London. Read the full press release here https://lnkd.in/ezAJzGv5 💡 Dr Jue Wang will explore the fascinating evolution of computational protein design and how machine learning is shaping the future of therapeutics. As Co-lead of the Protein Design Team at Google DeepMind, he brings a wealth of experience in deep learning, synthetic biology, and sustainability. 💡 Dr Robert Grundy will delve into the power of AI and collaboration in drug discovery, sharing insights from his 25+ years across pharma and biotech. As CEO of Intelligent OMICS, he is at the forefront of using big data to revolutionize target discovery. Join us to hear from these visionary leaders and explore how “Big molecules to big data…thinking BIG to drive innovative research” is transforming the drug discovery landscape. 🔬 Expect inspiring talks, cutting-edge research, and opportunities to connect with fellow innovators across pharma, biotech, and academia. 📅 Save the date: 10–11 March 2025 📍 Location: The Royal Society of Medicine, London 💻 Register free now: https://lnkd.in/ez6wzN7C #ELRIG #ResearchAndInnovation #DrugDiscovery #BigData #BigMolecules #AI #ProteinDesign #ScienceInnovation #Networking #ELRIGRI2025 #RI2025 Sarah Brockbank Roger Clark Marijn Vlaming Arpan Desai Thierry Dorval Sara Imarisio Sanj Kumar Melanie Leveridge

Exciting News! 🌟 We are thrilled to announce the publication of our latest paper by the Intellomx team in the journal Functional and Integrative Genomics. This research represents a significant milestone in our ongoing efforts to advance the field of genomics and personalized medicine demonstrating how Intellomx's unique approach to harnessing machine learning can reveal important insights into the key molecular drivers of disease biology. A heartfelt thank you to our dedicated team for their hard work and commitment to innovation. We're proud of what we've achieved together and excited for what's to come! https://lnkd.in/eDcZVsmc #NewPublication #Intellomx #Genomics #Innovation #Research #AML #AL #MachineLearning #DrugDiscovery Chinyere I. Ajonu Dimitrios Zafeiris Graham Ball

How much impact has AI really had on our ability to develop drugs? Probably more than we appreciate. We discuss the perception of AI following 10 years of it's use in developing medicines.

In conversation with Tim Roberts for Business Spotlight UK our CEO Robert Grundy MBE discusses the work of Intelligent OMICS Ltd, the business of science and innovation and his own personal approach to impact and work life balance. https://lnkd.in/dmjXdTur

How much impact has AI really had on our ability to develop drugs? Probably more than we appreciate. We discuss the perception of AI following 10 years of it's use in developing medicines.

Intellomx are very excited to be collaborating with Charnwood Discovery to bring our unique AI driven OMICS analysis platform alongside Charnwood's first in class small molecule drug discovery and development capability. Together we are able to provide drug discovery groups with the capability to enable transformational first-in-class therapeutics that will have significant impact on the development of novel medicines. https://lnkd.in/ev2rN5mY

Increasingly we are finding that the Intellomx approach to interrogating OMICS data sets is enabling a much better appreciation of poorly understood and potentially druggable pathways - the dark biology of disease. #AI #machinelearning #drugdiscovery #computationalbiology #discoverybiology

In conversation with Tim Roberts for Business Spotlight UK our CEO Robert Grundy MBE discusses the work of Intelligent OMICS Ltd, the business of science and innovation and his own personal approach to impact and work life balance. https://lnkd.in/dmjXdTur

Our CEO Robert Grundy MBE has been spending the last two days at Johnson & Johnson Innovative Medicine centre in London in the company of J&J innovators and other JLABS companies at the EMEA CEO summit discussing the impact of AI on drug discovery and development.